Ultracet

Ultracet is a brand name of acetaminophen/tramadol, approved by the FDA in the following formulation(s):

ULTRACET (acetaminophen; tramadol hydrochloride - tablet; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: August 15, 2001
  
  Strength(s): 325MG;37.5MG ^[RLD][AB]

Has a generic version of Ultracet been approved?

A generic version of Ultracet has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ultracet and have been approved by the FDA:

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (acetaminophen; tramadol hydrochloride tablet; oral)

• 
  Manufacturer: AMNEAL PHARMS
  
  Approval date: December 9, 2009
  
  Strength(s): 325MG;37.5MG ^[AB]


• 
  Manufacturer: CARACO
  
  Approval date: December 16, 2005
  
  Strength(s): 325MG;37.5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: September 26, 2008
  
  Strength(s): 325MG;37.5MG ^[AB]


• 
  Manufacturer: PAR PHARM
  
  Approval date: April 21, 2005
  
  Strength(s): 325MG;37.5MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: July 26, 2006
  
  Strength(s): 325MG;37.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ultracet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Composition comprising a tramadol material and acetaminophen and its use
  Patent RE39221
  Issued: August 1, 2006
  Inventor(s): Raffa; Robert B. & Vaught; Jeffrey L.
  Assignee(s): Ortho-McNeil Pharmaceutical, Inc.
  This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).
  
  Patent expiration dates:
  
  
  • August 9, 2011
    
    ✓ 
    Patent use: TREATMENT OF PAIN
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Ultracet Consumer Information (Drugs.com)
• Ultracet Consumer Information (Wolters Kluwer)
• Ultracet Consumer Information (Cerner Multum)
• Ultracet Advanced Consumer Information (Micromedex)
• Tramadol/Acetaminophen Consumer Information (Wolters Kluwer)
• Acetaminophen and tramadol Consumer Information (Cerner Multum)
• Tramacet Advanced Consumer Information (Micromedex)
• Tramadol and acetaminophen Advanced Consumer Information (Micromedex)